DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives angiotensin II-induced vascular remodeling through regulating mitochondrial fragmentation-Reference-Cited by-同舟云学术

DNA-dependent protein kinase catalytic subunit (DNA-PKcs) drives angiotensin II-induced vascular remodeling through regulating mitochondrial fragmentation

Published:2023-11 Issue: Volume:67 Page:102893
ISSN:2213-2317
Container-title:Redox Biology
language:en
Short-container-title:Redox Biology

Author:

Wang Litao,Wu Lin,Du Yuxin,Wang Xiang,Yang Bingsheng,Guo Shuai,Zhou Yuan,Xu Yiming,Yang Shuofei,Zhang Yingmei,Ren Jun^ORCID

Funder

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Organic Chemistry,Biochemistry,Clinical Biochemistry

Reference60 articles.

1. Large-artery stiffness in health and disease: JACC state-of-the-art review;Chirinos;J. Am. Coll. Cardiol.,2019

2. Cerro-Pardo I, et al. Galectin-1 prevents pathological vascular remodeling in atherosclerosis and abdominal aortic aneurysm;Roldan-Montero;Sci. Adv.,2022

3. Smooth muscle phenotypic modulation--a personal experience;Campbell;Arterioscler. Thromb. Vasc. Biol.,2012

4. Vascular smooth muscle cells and arterial stiffening: relevance in development, aging, and disease;Lacolley;Physiol. Rev.,2017

5. Dimers of DNA-PK create a stage for DNA double-strand break repair;Chaplin;Nat. Struct. Mol. Biol.,2021

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Angiotensin II: Role in oxidative stress, endothelial dysfunction, and diseases;Molecular and Cellular Endocrinology;2024-10

2. DNA sensors in metabolic and cardiovascular diseases: Molecular mechanisms and therapeutic prospects;Immunological Reviews;2024-08-19

3. The multifaceted functions of DNA‐PKcs: implications for the therapy of human diseases;MedComm;2024-06-19

4. FBXL4 protects against HFpEF through Drp1-Mediated regulation of mitochondrial dynamics and the downstream SERCA2a;Redox Biology;2024-04

5. DNA-PKcs Phosphorylates Cofilin2 to Induce Endothelial Dysfunction and Microcirculatory Disorder in Endotoxemic Cardiomyopathy;Research;2024-01